Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma

Recommendations for the Management of Rare Kidney Cancers

(2017) Rachel H. Giles et al.   EUROPEAN UROLOGY

Clinical activity of PD1/PDL1 inhibitors in metastatic non-clear cell renal cell carcinoma (nccRCC).

(2017) Raphael Brandao Moreira et al.   JOURNAL OF CLINICAL ONCOLOGY

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

(2016) Nizar M. Tannir et al.   EUROPEAN UROLOGY

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

(2016) Holger Moch et al.   EUROPEAN UROLOGY

Emerging therapeutics in refractory renal cell carcinoma

(2016) Vadim S. Koshkin et al.   EXPERT OPINION ON PHARMACOTHERAPY

The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma

(2016) Moshe C. Ornstein et al.   Expert Review of Anticancer Therapy

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

(2016) Andrew J Armstrong et al.   LANCET ONCOLOGY

Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients

(2016) Levente Kuthi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis

(2015) Francisco E. Vera-Badillo et al.   EUROPEAN UROLOGY

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

(2015) Jenny J Ko et al.   LANCET ONCOLOGY

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

(2015) Robert J. Motzer et al.   NEW ENGLAND JOURNAL OF MEDICINE

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation

(2015) R. W. Joseph et al.   Cancer Immunology Research

PD-L1 expression in nonclear-cell renal cell carcinoma

(2014) T. K. Choueiri et al.   ANNALS OF ONCOLOGY